Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...
This site uses cookies to provide you with a better browsing experience. By accepting this banner, scrolling down this page, clicking on a link or continuing to browse in any other way, you consent to the use of cookies. If want to know more read our cookie policy. AcceptRead the policy
